Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis

This study has been completed.
Sponsor:
Collaborator:
Kyowa Hakko Kogyo Co., Ltd.
Information provided by:
University of Mississippi Medical Center
ClinicalTrials.gov Identifier:
NCT00227058
First received: September 23, 2005
Last updated: January 24, 2007
Last verified: January 2007
  Purpose

The purpose of this study is to learn if two nutritional supplements, Orotic Acid and Glutathione will have any effect on the immune system response and if there will be any effect on the symptoms of seasonal allergies. It is our thinking that they will have an positive effect.


Condition Intervention
Seasonal Allergic Rhinitis
Drug: Orotic acid and Glutathione-(Nutritional Supplements)

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Diagnostic
Official Title: Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic

Resource links provided by NLM:


Further study details as provided by University of Mississippi Medical Center:

Primary Outcome Measures:
  • Improvement in nasal symptom scores from baseline after intervention

Secondary Outcome Measures:
  • change in cytokine profile with intervention compared to placebo

Estimated Enrollment: 100
Study Start Date: January 2005
Estimated Study Completion Date: November 2005
Detailed Description:

Current therapy for most immune-based diseases center around the use of anti inflammatory agents, many of which have unpleasant or dangerous side effects. Allergic rhinitis affects over 40 million Americans and its morbidity results from a combination of physical and psychological symptoms. The primary immunopathology has been defined as an imbalance of TH1/TH2 cytokines production resulting in increased allergen-specific IgE production, mast cell activation and eosinophil recruitment/activity. Metallic salts of orotic acid (OR), a natural intermediate in pyrimidine nucleic acid synthesis have been utilized to improve the signs and symptoms of a variety of maladies including the common cold, allergies and as preventatives for cancer and heart disease. Recent studies have reported that moderate doses of OR can mitigate or prevent endocrine and subjective psychological stresses in an acute laboratory stress model. All these findings lead us to hypothesize that OR salts administration will alleviate or eliminate the signs and symptoms associated with seasonal AR through a protective effect that involves direct anti-inflammatory immune effects and/or immunomodulation that include leukocyte trafficking, immunoregulatory cytokine balance and/or decrease inflammatory cell activity.

  Eligibility

Ages Eligible for Study:   18 Years to 64 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: Participants must have allergic rhinitis and be skin test positive to Bermuda Grass, Johnson grass, oak tree and/or ragweed, be symptomatic -

Exclusion Criteria: Any significant known heath disease: cardiovascular disease, cancer, or any metabolic disorder, smoker

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00227058

Locations
United States, Mississippi
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216
Sponsors and Collaborators
University of Mississippi Medical Center
Kyowa Hakko Kogyo Co., Ltd.
Investigators
Principal Investigator: Gailen D. Marshall, MD/PhD University of Mississippi Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00227058     History of Changes
Other Study ID Numbers: KHK040213
Study First Received: September 23, 2005
Last Updated: January 24, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of Mississippi Medical Center:
allergic rhinitis

Additional relevant MeSH terms:
Rhinitis, Allergic, Perennial
Rhinitis
Rhinitis, Allergic, Seasonal
Nose Diseases
Respiratory Tract Diseases
Respiratory Hypersensitivity
Otorhinolaryngologic Diseases
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Respiratory Tract Infections

ClinicalTrials.gov processed this record on September 18, 2014